New bipartisan House bill includes major PBM reforms
A bipartisan House bill introduced Friday afternoon would add all sorts of new transparency measures around healthcare and serve up major PBM reforms as members of Congress on both sides of the aisle look to shake up the way pharma middlemen operate.
The 231-page bill, known as the Lower Costs, More Transparency Act, includes provisions that would ban spread pricing in Medicaid and require PBMs to semi-annually provide employers with detailed data on drug spending, out-of-pocket spending, formulary placement rationale and aggregate rebate information.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
